Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what — from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,397 filings

Top spenders & firms Spend by issue

Clear
Q4
VAN SCOYOC ASSOCIATES for ZEBRA TECHNOLOGIES CORP.
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · Senate · $30,000.00 income
Consumer Issues/Safety/Products, Pharmacy
View →
Q4
BLUECROSS BLUESHIELD OF TENNESSEE for BLUECROSS BLUESHIELD OF TENNESSEE
4th Quarter (Oct 1 - Dec 31) 2025 · Tennessee · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q4
FORBES-TATE for INDEPENDENT PHARMACY COOPERATIVE
4th Quarter (Oct 1 - Dec 31) 2025 · Wisconsin · House · Senate · $30,000.00 income
Health Issues, Pharmacy, Medicare/Medicaid, Budget/Appropriations
View →
Q4
ALB SOLUTIONS for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Connecticut · House · Senate · $40,000.00 income
Pharmacy
View →
Q4
SALT POINT STRATEGIES for VERTEX PHARMACEUTICALS
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View →
Q4
FORBES-TATE for CALIFORNIA LIFE SCIENCES ASSOCIATION
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $40,000.00 income
Health Issues, Manufacturing, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q4
CAPITOL COUNSEL LLC for PCCA, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Texas · House · Senate · $60,000.00 income
Pharmacy
View →
Q4
RUBICON ADVISORS, LLC for HENRY MEDS
4th Quarter (Oct 1 - Dec 31) 2025 · Delaware · House · Senate · $60,000.00 income
Pharmacy
View →
Q4
RUBICON ADVISORS, LLC for IMMUNIZATION ALLIANCE FOR EQUITY AND ACCESS
4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · $45,000.00 income
Pharmacy
View →
Q4
RUBICON ADVISORS, LLC for ALZHEON
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · $12,000.00 income
Pharmacy
View →
Q4
RUBICON ADVISORS, LLC for HYPOPARATHYROIDISM ASSOCIATION
4th Quarter (Oct 1 - Dec 31) 2025 · California
Pharmacy
View →
Q4
RUBICON ADVISORS, LLC for ASCENDIS PHARMA, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · $60,000.00 income
Pharmacy
View →
Q4
RUBICON ADVISORS, LLC for DR. REDDY'S LABORATORIES, LTD
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $60,000.00 income
Pharmacy
View →
Q4
RUBICON ADVISORS, LLC for DYNAVAX TECHNOLOGIES
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $75,000.00 income
Pharmacy
View →
Q4
FORBES-TATE for PHRMA
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $80,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy, Consumer Issues/Safety/Products
View →
Q4
MASON STREET CONSULTING, LLC for CAPITAL RX INC.
4th Quarter (Oct 1 - Dec 31) 2025 · New York · House · Senate · $50,000.00 income
Pharmacy
View →
Q4
INVARIANT LLC for SK AMERICAS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · New York · House · Senate · $140,000.00 income
Energy/Nuclear, Environment/Superfund, Science/Technology, Pharmacy
View →
Q4
HOLLAND & KNIGHT LLP for VIATRIS INC
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Pharmacy
View →
3T
MASON STREET CONSULTING, LLC for DOMPE US INC.
3rd Quarter (July 1 - Sep 30) 2025 · California
Pharmacy, Tariff (miscellaneous tariff bills)
View →
Q4
RADIUS ADVOCACY, LLC for HEALTHCARE DISTRIBUTION ALLIANCE
4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · $50,000.00 income
Pharmacy
View →
Q4
RADIUS ADVOCACY, LLC for HEALTHCARE DISTRIBUTION ALLIANCE
4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · $50,000.00 income
Pharmacy
View →
Q4
DESIMONE CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $40,000.00 income
Pharmacy
View →
Q4
TODD STRATEGY GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q4
TODD STRATEGY GROUP for ASTELLAS PHARMA US, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Illinois · House · Senate · $50,000.00 income
Pharmacy, Health Issues
View →
Q4
BROWNSTEIN HYATT FARBER SCHRECK, LLP for ELI LILLY AND COMPANY, FORMERLY REPORTED AS, LILLY USA, LLC
4th Quarter (Oct 1 - Dec 31) 2025 · Indiana · House · Senate · $90,000.00 income
Pharmacy, Health Issues
View →
Previous Page 10 of 56 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem